Phylogenetic diversity and low level antiretroviral resistance mutations in HIV type 1 treatment-naive patients from Cape Town, South Africa

scientific article published on July 2008

Phylogenetic diversity and low level antiretroviral resistance mutations in HIV type 1 treatment-naive patients from Cape Town, South Africa is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1089/AID.2008.0028
P698PubMed publication ID18593350
P5875ResearchGate publication ID5258758

P50authorJochen BodemQ39050766
Wolfgang PreiserQ41113731
Susan EngelbrechtQ42584466
Graeme B JacobsQ58881081
P2093author name stringAxel Rethwilm
Annette Laten
Estrelita Janse van Rensburg
Benedikt Weissbrich
P433issue7
P921main subjectSouth AfricaQ258
Cape TownQ5465
phylogeneticsQ171184
anti-retroviral agentQ50430310
P304page(s)1009-1012
P577publication date2008-07-01
P1433published inAIDS Research and Human RetrovirusesQ4651880
P1476titlePhylogenetic diversity and low level antiretroviral resistance mutations in HIV type 1 treatment-naive patients from Cape Town, South Africa
P478volume24

Reverse relations

cites work (P2860)
Q46692659Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon
Q36404211Construction of a high titer infectious HIV-1 subtype C proviral clone from South Africa
Q91711639Drug Resistance Mutations Against Protease, Reverse Transcriptase and Integrase Inhibitors in People Living With HIV-1 Receiving Boosted Protease Inhibitors in South Africa
Q38400463Executive Dyscontrol of Learning and Memory: Findings from a Clade C HIV-positive South African Sample
Q28476627HIV drug resistance (HIVDR) in antiretroviral therapy-naïve patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high
Q35120358HIV-1 diversity in an antiretroviral treatment naïve cohort from Bushbuckridge, Mpumalanga Province, South Africa.
Q34219941HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naïve to HAART in Cameroon
Q28540635HIV-1 subtypes B and C unique recombinant forms (URFs) and transmitted drug resistance identified in the Western Cape Province, South Africa
Q47554143HIV-Positive Kidney Donor Selection for HIV-Positive Transplant Recipients
Q37385691HIV-positive-to-HIV-positive kidney transplantation--results at 3 to 5 years
Q43187668HIV-positive-to-HIV-positive kidney transplantation.
Q28554729Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey
Q30357556Molecular epidemiology of HIV in two highly endemic areas of northeastern South Africa.
Q57708766Monitoring HIV drug resistance in treatment-naive individuals: molecular indicators, epidemiology and clinical implications
Q37024000Neuroimaging markers of human immunodeficiency virus infection in South Africa
Q35006672Phylogenetic studies of transmission dynamics in generalized HIV epidemics: an essential tool where the burden is greatest?
Q35305667Prevalence of antiretroviral drug resistance mutations and HIV-I subtypes among newly-diagnosed drug-naïve persons visiting a voluntary testing and counselling centre in northeastern South Africa
Q34129300Primary drug resistance in South Africa: data from 10 years of surveys
Q43146308Replicative capacity differences of thymidine analog resistance mutations in subtype B and C human immunodeficiency virus type 1.
Q44710836Resistance to antiretroviral drugs in newly diagnosed, young treatment-naïve HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa.
Q33567164Transmitted drug resistance in nonsubtype B HIV-1 infection
Q38366033Transplantation in resource-limited setting: using HIV-positive donors for HIV-positive patients
Q50190206Transplantation in resource-limited setting: using HIV-positive donors for HIV-positive patients
Q64245959Trends in Pretreatment HIV-1 Drug Resistance in Antiretroviral Therapy-naive Adults in South Africa, 2000-2016: A Pooled Sequence Analysis

Search more.